Submit Deal

BROKEN STRING BIOSCIENCES

Summary

Broken String Biosciences, a genomics company building a technology platform to drive the development of cell and gene therapies that are safer by design.

Deals Overview

Total Deals1

Valued Deals1

Total Value£ 12 M

Avg. Deal Size£ 12 M

Market Context

Senior Management

Felix Dobbs
CEO

Sort

18 Sep 2023|United Kingdom|Biotechnology

Target: BROKEN STRING BIOSCIENCES

Bidder: ILLUMINA VENTURES

8 Service Providers

2 Target | 6 Bidder

13 Dealmakers

2 Target | 11 Bidder

£ 12 M

Value

By continuing, you agree to our Terms & Conditions and our Data Privacy Policy